Safety of intra-arterial chemotherapy with or without osmotic blood–brain barrier disruption for the treatment of patients with brain tumors is a dataset published in Neuro-Oncology Advances (2022). On theSindex it has a DataRank of 0.896, placing it in the top 22.5% of the data-sharing corpus. It has been cited 24 times, with 23 citing works in its 1-hop citation network.
Ranks in the top 23% for downstream scientific impact
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.483
From this paper's citation signal
Citation Network Contribution
0.413
From 15 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 23 citers.
National Institutes of Health
Grant: CA199111
National Institutes of Health
Grant: CA137488
Veterans Administration Merit Review
Grant: BX003897
National Institutes of Health
Grant: 5R01CA137488-15
Two Compartment Models to Improve Brain Tumor Therapy
National Institutes of Health
Grant: 5R13CA086959-07
The Annual Blood-Brain Barrier Consortium Meeting
National Institutes of Health
Grant: 5R01CA199111-35
Opening of the Blood-Brain Barrier to Antitumor Agents
Jonathan D. Lewis Foundation
Walter S. and Lucienne Driskill Foundation
FWCI
2.32
Citation Percentile
0.9%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals